CN108853237B - 一种治疗银屑病的外用药及其制备方法 - Google Patents
一种治疗银屑病的外用药及其制备方法 Download PDFInfo
- Publication number
- CN108853237B CN108853237B CN201811121114.6A CN201811121114A CN108853237B CN 108853237 B CN108853237 B CN 108853237B CN 201811121114 A CN201811121114 A CN 201811121114A CN 108853237 B CN108853237 B CN 108853237B
- Authority
- CN
- China
- Prior art keywords
- cortex
- treating psoriasis
- parts
- medicine
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000004681 Psoriasis Diseases 0.000 title claims abstract description 53
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 238000002791 soaking Methods 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 206010067484 Adverse reaction Diseases 0.000 abstract description 6
- 230000006838 adverse reaction Effects 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 206010012735 Diarrhoea Diseases 0.000 abstract description 4
- 208000001848 dysentery Diseases 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000004438 eyesight Effects 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 244000045947 parasite Species 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 230000000622 irritating effect Effects 0.000 abstract description 2
- 230000002147 killing effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 231100000167 toxic agent Toxicity 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 6
- 230000035618 desquamation Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000001503 joint Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 2
- 241001536358 Fraxinus Species 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000218681 Pseudolarix Species 0.000 description 2
- 241001446509 Psoralea Species 0.000 description 2
- 206010037575 Pustular psoriasis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241001313087 Carpinus laxiflora Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241001501111 Erycibe Species 0.000 description 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 241000588214 Fraxinus chinensis subsp. rhynchophylla Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 208000004526 exfoliative dermatitis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000023368 generalized pustular psoriasis Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 201000010914 pustulosis of palm and sole Diseases 0.000 description 1
- 208000011797 pustulosis palmaris et plantaris Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗银屑病的外用药及其制备方法。所述治疗银屑病的外用药,通过采用补骨脂、秦皮、土槿皮、丹皮、白鲜皮为原料并进行适合的重量配比,方中补骨脂具有温肾助阳、纳气、止泻的作用;秦皮具有清热燥湿,收涩止痢,止带,明目的作用;土槿皮具有祛风除湿,杀虫止痒的作用;丹皮具有清热凉血、活血化瘀的作用;白鲜皮具有祛风,燥湿,清热,解毒的作用。最终制备得到的治疗银屑病的外用药,各种原料组分协同作用,标本兼治,扶正祛邪,治疗银屑病效果显著且不良反应少,治愈率高,治疗方便,温和无刺激,本发明组方和制备工艺简单,适合大规模工业化生产。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗银屑病的外用药及其制备方法。
背景技术
银屑病俗称牛皮癣,是一种慢性复发性炎症性皮肤病,病程较长,有的病例几乎终生不愈,需要长期治疗。该病发病以青壮年为主,对患者的身体健康和精神状况影响较大。临床上常分为寻常型、脓疱型、红皮病型、关节病型:寻常型银屑病为最常见的一型,典型表现为境界清楚、形状大小不一的红斑,周围有炎性红晕。稍有浸润增厚。表面覆盖多层银白色鳞屑。皮损好发于头部、骶部和四肢伸侧面。部分患者自觉不同程度的瘙痒;脓疱型银屑病较少见,分泛发型和掌跖型。泛发性脓疱型银屑病是在红斑上出现群集性浅表的无菌性脓疱,部分可融合成脓湖。急性发病或突然加重时常伴有寒战、发热、关节疼痛、全身不适和白细胞计数增多等全身症状。多呈周期性发作,在缓解期往往出现寻常型银屑病皮损。掌跖脓疱病皮损局限于手足,对称发生,一般状况良好,病情顽固,反复发作;红皮病型银屑病又称银屑病性剥脱性皮炎,是一种严重的银屑病。常因治疗不恰当,长期大量应用糖皮质激素,减量过快或突然停药所致。表现为全身皮肤弥漫性潮红、肿胀和脱屑,往往伴有发热、畏寒、不适等全身症状,因为皮肤有破损,患者抵抗力下降,有时合并菌血症或者脓毒血症;关节病型银屑病又称银屑病性关节炎。银屑病患者同时发生类风湿性关节炎样的关节损害,可累及全身大小关节,但以末端指(趾)节间关节病变最具特征性。受累关节红肿疼痛,关节周围皮肤也常红肿。
目前治疗银屑病的主要外用药有维生素D3类似物、糖皮质激素、免疫抑制剂等;内服药有甲氨蝶呤、维a酸类以及一些中药制剂如雷公藤、复方丹参片等;物理疗法如紫外线、光化学疗法等。目前大部分治疗银屑病的药物都有一定的副作用。在我国,治疗银屑病的口服药物存在影响血脂、肝功能、血象、血压、抑制免疫等不良反应;外用药物同样存在导致毛细血管扩张、刺激等不良反应。此外,如果患者长期用这些药物治疗,其对药物的敏感性会逐渐下降。且部分患者因为有合并症,不能采用上述治疗手段,亟需提供一种不良反应少、治疗方便且有效的治疗银屑病的方法。
发明内容
为了解决现有技术中存在的上述问题,本发明提供一种治疗银屑病效果显著且不良反应少,治愈率高,治疗方便,温和无刺激,组方和制备工艺简单,适合大规模工业化生产的治疗银屑病的外用药,并提供其制备方法。
本发明的技术方案为:
一种治疗银屑病的外用药,原料组分包括:
补骨脂30-300重量份、秦皮50-500重量份、土槿皮50-500重量份、丹皮50-500重量份、白鲜皮50-500重量份。
进一步地,所述治疗银屑病的外用药的原料组分包括:
补骨脂90-240重量份、秦皮150-400重量份、土槿皮150-400重量份、丹皮150-400重量份、白鲜皮150-400重量份。
进一步地,所述治疗银屑病的外用药的原料组分包括:
补骨脂150重量份、秦皮250重量份、土槿皮250重量份、丹皮250重量份、白鲜皮250重量份。
一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后加水浸泡,然后进行第一次煎煮,过滤,得第一滤液;向所述过滤后的滤渣中加水,然后进行第二次煎煮,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
进一步地,所述浸泡的加水量为加水至淹没中药材以上5-8cm。
进一步地,所述浸泡的时间为20-40min。
进一步地,所述第一次煎煮的火候为先武火煮开,然后文火煎煮。
进一步地,所述第一次煎煮的时间为10-20min。
进一步地,所述第二次煎煮加水量为加水至淹没中药材以上3-5cm。
进一步地,所述第二次煎煮的火候为先武火煮开,然后文火煎煮;所述第二次煎煮的时间为10-20min。
为了便于理解本发明,现对本发明中的原料药及药效作进一步阐述。
补骨脂:为豆科植物补骨脂的干燥果实。秋季果实成熟时采收,除去杂质,晒干。性温,味辛、苦,归肾经、脾经。温肾助阳、纳气、止泻。用于治疗肾阳不足、命门火衰之腰膝冷痛、阳痿、遗精、尿频、脾肾阳虚泄泻、肾不纳气之虚喘、白癜风、牛皮癣等。现代药理研究表明补骨脂能扩张冠状动脉;能收缩子宫及缩短出血时间,减少出血量;抗早孕和有雌激素样作用;有致光敏作用,内服或外涂皮肤,经日光或紫外线照射,可使局部皮肤色素沉着;有抗肿瘤、抗衰老、抑菌、杀虫及雌激素样作用。
秦皮:为木犀科植物苦枥白蜡树、白蜡树、尖叶白蜡树或宿柱白蜡树的干燥枝皮或干皮。春、秋季剥取枝皮或干皮,晒干。味苦、涩,性寒,归肝、胆、大肠经。清热燥湿,收涩止痢,止带,明目。用于治疗湿热泻痢,赤白带下,目赤肿痛,目生翳膜。现代药理研究表明秦皮可抗菌、抗炎、镇痛,可用于“痛风”性关节炎,有止咳、祛痰、平喘作用。
土槿皮:松科植物金钱松的干燥根皮或近根树皮。秋末挖根,洗净,剥取根皮,刮去外皮后晒干,夏季剥取树皮,晒干。性温,味辛、苦,归肺经、脾经。祛风除湿,杀虫止痒。用于治疗疥癣,湿疹,神经性皮炎。现代药理研究表明土槿皮具有抗真菌、抗生育、止血、对肝癌细胞活性有影响。
丹皮:为毛茛科植物牡丹干燥根皮。秋季采挖根部,除去细根,剥取根皮,晒干。生用或炒用。味苦、辛,性微寒,归心、肝、肾经。清热凉血、活血化瘀。用于治疗温毒发斑、吐血衄血、夜热早凉、无汗骨蒸、经闭痛经、痈肿疮毒、跌打伤痛。现代药理研究表明,丹皮所含牡丹酚及其以外的糖苷类成分均有抗炎作用;牡丹皮的甲醇提取物有抑制血小板作用;牡丹酚有镇静、降温、解热、镇痛、解痉等中枢抑制作用及抗动脉粥样硬化、利尿、抗溃疡等作用。
白鲜皮:为芸香科多年生草本植物白藓的干燥根皮。北方于春、秋二季采收,南方于夏季采收,洗净泥土,除去须根及粗皮并纵向剖开,抽去木心后晒干。味苦、咸,性寒,归脾、胃经。祛风,燥湿,清热,解毒。用于治疗风热疮毒、疥癣、皮肤痒疹、风湿痹痛、黄疸。现代药理研究表明,白藓皮对多种致病真菌具有抑制作用;能增强心肌收缩力,收缩血管;对子宫及肠平滑肌有强力的收缩作用;抑制免疫功能,尚具有一定的抗癌作用。
本发明的有益效果为:
本发明所述的治疗银屑病的外用药,通过采用补骨脂、秦皮、土槿皮、丹皮、白鲜皮为原料并进行适合的重量配比,方中补骨脂具有温肾助阳、纳气、止泻的作用;秦皮具有清热燥湿,收涩止痢,止带,明目的作用;土槿皮具有祛风除湿,杀虫止痒的作用;丹皮具有清热凉血、活血化瘀的作用;白鲜皮具有祛风,燥湿,清热,解毒的作用。最终制备得到的治疗银屑病的外用药,各种原料组分协同作用,标本兼治,扶正祛邪,治疗银屑病效果显著且不良反应少,治愈率高,治疗方便,温和无刺激,本发明组方和制备工艺简单,适合大规模工业化生产。
具体实施方式
下面通过具体实施例,对本发明作进一步说明。
实施例1
本实施例提供一种治疗银屑病的外用药,原料组分包括:
补骨脂30g、秦皮50g、土槿皮50g、丹皮50g、白鲜皮50g。
进一步,提供一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后,加水至淹没中药材以上5cm后浸泡20min,武火煮开后文火第一次煎煮10min,过滤,得第一滤液;向所述过滤后的滤渣中加水至淹没中药材以上3cm,武火煮开后文火第二次煎煮10min,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
实施例2
本实施例提供一种治疗银屑病的外用药,原料组分包括:
补骨脂300g、秦皮500g、土槿皮500g、丹皮500g、白鲜皮500g。
进一步,提供一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后,加水至淹没中药材以上8cm后浸泡40min,武火煮开后文火第一次煎煮20min,过滤,得第一滤液;向所述过滤后的滤渣中加水至淹没中药材以上5cm,武火煮开后文火第二次煎煮20min,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
实施例3
本实施例提供一种治疗银屑病的外用药,原料组分包括:
补骨脂90g、秦皮150g、土槿皮150g、丹皮150g、白鲜皮150g。
进一步,提供一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后,加水至淹没中药材以上6cm后浸泡40min,武火煮开后文火第一次煎煮20min,过滤,得第一滤液;向所述过滤后的滤渣中加水至淹没中药材以上6cm,武火煮开后文火第二次煎煮20min,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
实施例4
本实施例提供一种治疗银屑病的外用药,原料组分包括:
补骨脂240g、秦皮400g、土槿皮400g、丹皮400g、白鲜皮400g。
进一步,提供一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后,加水至淹没中药材以上7cm后浸泡30min,武火煮开后文火第一次煎煮15min,过滤,得第一滤液;向所述过滤后的滤渣中加水至淹没中药材以上7cm,武火煮开后文火第二次煎煮15min,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
实施例5
本实施例提供一种治疗银屑病的外用药,原料组分包括:
补骨脂150g、秦皮250g、土槿皮250g、丹皮250g、白鲜皮250g。
进一步,提供一种制备所述治疗银屑病的外用药的方法,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后,加水至淹没中药材以上7cm后浸泡30min,武火煮开后文火第一次煎煮15min,过滤,得第一滤液;向所述过滤后的滤渣中加水至淹没中药材以上7cm,武火煮开后文火第二次煎煮15min,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
临床效果实验
根据患者病情酌情制定不同疗程的治疗方案,本发明治疗患者156例,有效率94.65%,典型病例如下:
杨××,男,48岁,病程10年,就诊于多家大医院,应用过多种治疗方式均效果不佳,皮损控制不佳,且易反复,不伴有关节痛。既往有丙型肝炎。2013年9月就诊,查体可见躯干四肢大片斑块,表面鳞屑,该患者病情较重,但因为有丙型肝炎,免疫抑制剂、生物制剂均不合适,给予本发明实施例2中药洗浴和实施例1外用,治疗30天左右,脱屑结痂明显减轻,3个月左右症状消失,随访3年未复发。
陈××,女,45岁,病程20年,在当地医院治疗未痊愈,2010年5月就诊,查体可见躯干、四肢红色斑丘疹,不痒,有少量脱屑,给予本发明实施例1中药外用和实施例2洗浴后30天症状完全消失。后复发3次,同样方案治疗均在两周内症状消失。现随访4年未复发。
李××,男,32岁,病史1年,就诊于当地医院均未治愈,2014年就诊查体可见头面部及躯干四肢有散在鳞屑性红丘疹,因由生育需求,给予本发明实施例1外用,治疗40天左右症状完全消失,随访3年未复发。
许××,女,38岁,病史5年,因怀孕后出现,多处就诊并服用激素治疗均未痊愈,既往有乙肝病史。2012年就诊查体见全身多处红斑块,部分周边细小脓疱,少许脱屑。给予本发明实施例1外用及实施例2洗浴30天左右,皮肤红斑块明显变薄,颜色变暗,脱屑明显减少,2个月左右痊愈,随访4年未复发。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。
Claims (10)
1.一种治疗银屑病的外用药,其特征在于,由以下原料组分制成:
补骨脂30-300重量份、秦皮50-500重量份、土槿皮50-500重量份、丹皮50-500重量份、白鲜皮50-500重量份。
2.根据权利要求1所述的治疗银屑病的外用药,其特征在于,由以下原料组分制成:
补骨脂90-240重量份、秦皮150-400重量份、土槿皮150-400重量份、丹皮150-400重量份、白鲜皮150-400重量份。
3.根据权利要求1所述的治疗银屑病的外用药,其特征在于,由以下原料组分制成:
补骨脂150重量份、秦皮250重量份、土槿皮250重量份、丹皮250重量份、白鲜皮250重量份。
4.一种制备权利要求1-3任一项所述的治疗银屑病的外用药的方法,其特征在于,包括如下步骤:
依次称取补骨脂、秦皮、土槿皮、丹皮、白鲜皮,粉碎后加水浸泡,然后进行第一次煎煮,过滤,得第一滤液;向所述过滤后的滤渣中加水,然后进行第二次煎煮,过滤,得第二滤液;将所述第一滤液和所述第二滤液合并,即得所述治疗银屑病的外用药。
5.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述浸泡的加水量为加水至淹没中药材以上5-8cm。
6.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述浸泡的时间为20-40min。
7.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述第一次煎煮的火候为先武火煮开,然后文火煎煮。
8.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述第一次煎煮的时间为10-20min。
9.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述第二次煎煮加水量为加水至淹没中药材以上3-5cm。
10.根据权利要求4所述的制备治疗银屑病的外用药的方法,其特征在于,所述第二次煎煮的火候为先武火煮开,然后文火煎煮;所述第二次煎煮的时间为10-20min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811121114.6A CN108853237B (zh) | 2018-09-25 | 2018-09-25 | 一种治疗银屑病的外用药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811121114.6A CN108853237B (zh) | 2018-09-25 | 2018-09-25 | 一种治疗银屑病的外用药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108853237A CN108853237A (zh) | 2018-11-23 |
CN108853237B true CN108853237B (zh) | 2021-07-09 |
Family
ID=64324652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811121114.6A Active CN108853237B (zh) | 2018-09-25 | 2018-09-25 | 一种治疗银屑病的外用药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853237B (zh) |
-
2018
- 2018-09-25 CN CN201811121114.6A patent/CN108853237B/zh active Active
Non-Patent Citations (2)
Title |
---|
寻常型银屑病中医外治用药类别分析;郭昕炜等;《中医杂志》;20171031;第58卷(第19期);1658-1661 * |
自制补骨脂酊治疗寻常性银屑病;吕克己等;《中国皮肤性病学杂志》;19980531;第12卷(第3期);188-189 * |
Also Published As
Publication number | Publication date |
---|---|
CN108853237A (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547188A (zh) | 一种治疗静脉曲张的外用制剂及其制备方法 | |
CN103463516B (zh) | 一种治疗脚气的中药药膏及制备方法 | |
CN103735927B (zh) | 一种治疗痛风急性期的中药组合物及其制备方法 | |
CN102908391B (zh) | 一种治疗皮肤病的中药组合物及其制备方法和应用 | |
CN112807399A (zh) | 一种治疗皮肤病的中药酊剂及其制备方法 | |
CN102813900B (zh) | 一种治疗脚鸡眼的外用药 | |
CN104825944A (zh) | 一种治疗血热型银屑病的药物及其制备方法 | |
CN108853237B (zh) | 一种治疗银屑病的外用药及其制备方法 | |
CN106963912B (zh) | 一种治疗湿疹的降香复方组合物及其制备方法 | |
CN102895610A (zh) | 一种治疗水肿的药物 | |
CN104784346A (zh) | 一种治疗瘙痒症的中药洗剂制备方法 | |
CN104474279A (zh) | 一种治疗痰瘀互结证型乳癖病的中药 | |
CN105641564A (zh) | 一种采用中药内服外敷结合治疗痛风性关节炎的方法 | |
CN103877462A (zh) | 一种治疗牛皮癣的外用擦剂及其制备方法 | |
CN104225174A (zh) | 一种治疗冻伤的中药药膏及其制备方法 | |
CN105031596A (zh) | 一种治疗钱币状湿疹的软膏及其制备方法 | |
CN106728168B (zh) | 一种治疗湿疹、银屑病的中药外用制剂及其制备方法 | |
CN103933417A (zh) | 一种用于治疗皮肤病的中药制剂 | |
CN104056231B (zh) | 一种配合西医治疗老年性皮肤瘙痒症的中药组合物 | |
CN104367896B (zh) | 一种治疗气虚血瘀型中风的药物组合物及其制备方法 | |
CN103768454A (zh) | 一种具有预防和治疗hiv/aids的组合物及其制备方法 | |
CN102861161B (zh) | 治疗鳞屑角化型手足癣的中药湿巾的制备方法 | |
CN107854633A (zh) | 治疗痛风的组合物及其制备方法 | |
CN111067961B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN105169139A (zh) | 一种治疗皮肤病的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |